234080 — JW Life Science Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapContrarian

Annual balance sheet for JW Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5,078	28,873	28,374	9,622	10,489
Net Total Accounts Receivable
Net Total Receivables	37,198	53,772	55,731	59,862	44,795
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	64,430	105,008	107,834	105,664	88,289
Net Property, Plant And Equipment	137,145	131,555	124,577	132,051	128,653
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	219,467	252,942	255,836	325,324	318,206
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	83,902	80,044	94,259	80,179	84,428
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	87,975	112,610	96,443	124,879	97,628
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	131,492	140,332	159,393	200,445	220,578
Total Liabilities & Shareholders' Equity	219,467	252,942	255,836	325,324	318,206
Total Common Shares Outstanding